???global.info.a_carregar???
Peter Jervis is an experienced Research Chemist with a demonstrated history of working in both academia and the pharmaceutical industry (AstraZeneca, GlaxoSmithKline, Concept Life Sciences). He also has extensive experience in university teaching, scientific writing, and editing. He has published over 35 peer-reviewed research papers in international journals. He is a strong research professional, with a PhD in Organic and Medicinal Chemistry from the University of Birmingham. He has extensive experience presenting oral communications at various scientific meetings and congresses. He is skilled in organic chemistry, asymmetric synthesis, NMR spectroscopy, liquid chromatography-mass spectrometry (LC-MS), and natural product research. His current research interests are in the chemical synthesis and biological evaluation of cyanobacteria natural products. For more information, see https://orcid.org/0000-0002-5550-4535 or https://www.linkedin.com/in/peterjervis6/. Highlights: – Wide-ranging experience in organic chemistry and medicinal chemistry research. – 39 papers published in international peer-reviewed journals (15 as first author, 7 as corresponding author). Some of these papers are in high-ranking journals, such as Immunity (IF: 30), Nature Immunology (IF: 31), Journal of Clinical Investigation (IF: 19), Cancer Research (IF: 13) and PNAS (IF: 13). – Experienced in university chemistry teaching, including lectures, tutorials, workshops and laboratory demonstrating. Use of some innovative teaching methods, such as enquiry-based learning. – Experienced in designing chemistry modules and end of course assessments, e.g. NMR introductory course for foundation year students and retrosynthesis course for final year students.
Read full resume ↓
Identification

Personal identification

Full name
Peter Jervis
Gender
Male

Citation names

  • Jervis, Peter J
  • Jervis PJ

Author identifiers

Ciência ID
1719-37A3-4AA2
ORCID iD
0000-0002-5550-4535
Scopus Author Id
15020526900

Email addresses

  • pjervis@ciimar.up.pt (Professional)
  • peterjervis6@gmail.com (Personal)

Websites

Knowledge fields

  • Exact Sciences - Chemical Sciences - Organic Chemistry
  • Medical and Health Sciences - Basic Medicine - Medicinal Chemistry
  • Natural sciences - Biological Sciences - Biochemistry

Languages

Language Speaking Reading Writing Listening Peer-review
English (Mother tongue)
Portuguese Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
Spanish; Castilian Intermediate (B1) Upper intermediate (B2) Upper intermediate (B2) Intermediate (B1)
Education
Degree Classification
2004/09/01 - 2008/06/01
Concluded
 Organic Chemistry (Doctor of Philosophy)
University of Birmingham School of Chemistry, United Kingdom
"Stereoselective Intramolecular Allylation Routes to Oxygen-Containing Heterocycles - Supervisor: Dr. Liam R. Cox - Stereoselective synthesis of THPs/THFs via intramolecular reaction of an allylsilane and an aldehyde - Total synthesis of aureonitol" (THESIS/DISSERTATION)
2000/09/01 - 2004/07/01
Concluded
 Chemistry (Master)
University of Leicester Department of Chemistry, United Kingdom
"Classification: First Class Honours (combined 4-year bachelors's/masters) - Final year project: The synthesis of 2,6-dideoxy- and 2,6-dideoxy-6-fluoro-sugars (Prof. Jonathon M. Percy) - Completed total synthesis of olivose and 6-fluoro-olivose" (THESIS/DISSERTATION)
 First Class Honours
Affiliation

Science

Category
Host institution 		Employer
2024/09/02 - Current Researcher (Research) Universidade do Porto Centro Interdisciplinar de Investigação Marinha e Ambiental, Portugal
Universidade do Porto Centro Interdisciplinar de Investigação Marinha e Ambiental, Portugal
2019/05/23 - 2024/01/31 Researcher (Research) Universidade do Minho, Portugal
Universidade do Minho, Portugal
2018/07/09 - 2019/05/21 Researcher (Research) Universidade do Porto Faculdade de Farmácia, Portugal
Universidade do Porto Faculdade de Farmácia, Portugal
2017/10/01 - 2018/07/06 Researcher (Research) AstraZeneca UK Ltd Macclesfield, United Kingdom
AstraZeneca UK Ltd Macclesfield, United Kingdom
2016/06/01 - 2017/09/30 Researcher (Research) Concept Life Sciences Chapel-en-le-Frith, United Kingdom
Concept Life Sciences Chapel-en-le-Frith, United Kingdom
2014/09/01 - 2015/10/31 Researcher (Research) GlaxoSmithKline España, Spain
GlaxoSmithKline España, Spain
2008/05/01 - 2014/08/31 Researcher (Research) University of Birmingham School of Biosciences, United Kingdom
University of Birmingham School of Biosciences, United Kingdom
Projects

Grant

Designation Funders
2022/05/25 - 2022/12/24 BIOIMAGE CTO-21 - "Novos biomarcadores de imagem na avaliação de oclusãos coronarianas totais crônicas"
UMINHO/BIM-CNCG/2022/82
Researcher
Universidade do Minho, Portugal
Ongoing
2014/09/01 - 2015/10/31 Novel Inhibitors of Mycobacteria Tuberculosis Enzymes
GSK Open Lab
Invited Scientist Fellow
GlaxoSmithkline Investigación y Desarrollo, Spain
 GlaxoSmithKline Open Lab Foundation
2008/05/01 - 2014/08/31 Studying the Immune Response following Glycolipid Presentation by CD1d protein to iNKT cells
Wellcome-Trust
Post-doc Fellow
University of Birmingham School of Biosciences Centre for Systems Biology, United Kingdom
 Wellcome-Trust
Concluded
2004/09/01 - 2008/06/01 Stereoselective Intramolecular Allylation Routes to Oxygen-Containing Heterocycles
EPSRC PhD studentship
PhD Student Fellow
Engineering and Physical Sciences Research Council
Concluded

Contract

Designation Funders
2018/07/01 - 2021/06/30 Self-assembled minimalist peptide hydrogels inspired by mussel adhesive proteins for biomedical applications
FCT – PTDC/QUI-QOR/29015/2017
Researcher
Fundação para a Ciência e a Tecnologia
2018/07/10 - 2019/05/20 New Technologies for three Health Challenges of Modern Societies: Diabetes, Drug Abuse and Kidney Diseases
NORTE-01-0145-FEDER-000024
Researcher
Fundação para a Ciência e a Tecnologia
Outputs

Publications

Conference paper
  1. Peter J. Jervis; Inês Baptista; Luciana Martins; David M. Pereira; José A. Martins; Paula M. T. Ferreira. "Hydrogels and Nanostructures Formed from Ciprofloxacin–Peptide Conjugates". 2023.
    10.3390/IOCN2023-14493
  2. Jervis PJ; Moreira R; Ferreira PMT; Martins JA; Pereira DM. "'Self-Delivery' Using Anti-Inflammatory Hydrogels: Biological Evaluation of NSAID-Dehydrodipeptide Conjugates". 2020.
    10.3390/iocn2020-07897
  3. Amorim, C; Jervis PJ; Andrade J; Ferreira PMT; Martins JA. "Synthesis and characterisation of dimeric bolaamphiphilic dehydrodipeptides for biomedical applications.". 2020.
    10.3390/iocn2020-07994
Conference poster
  1. Oliveira, Carlos B.P. ; Jervis, Peter J; hilliou, loic; Ferreira, Paula M.T.; Martins, José A.. "New supramolecular hypergelators based on dehydroamino acid residues for biomedical applications". Paper presented in XXVI Encontro Galego Português de Química, 2022, 2022.
  2. Oliveira, Carlos B.P. ; Jervis, Peter J; hilliou, loic; Ferreira, Paula M.T.; Martins, José A.. "Development of new supramolecular hypergelators based on non-natural amino acid residues". Paper presented in ChemBioGels2021 International Symposium, 2021.
  3. Gomes, Valéria; Veloso, Sérgio; hilliou, loic; Jervis, Peter J; Ferreira, Paula; Castanheira, Elisabete M. S.. "New architectures in soft materials for combined cancer therapy: Multifunctional dehydrodipeptide-based hydrogels with magneto-plasmonic properties". Paper presented in ChemBioGels2021, 2021.
  4. Jervis, Peter; hilliou, loic; Renato B Pereira; Pereira, David M.; Martins, Jose A; Paula MT Ferreira. Corresponding author: Jervis, Peter. "A Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Hydrogel". Paper presented in INL EuroNanoForum 2021, 2021.
  5. Oliveira, Carlos B.P. ; Jervis, Peter J; Ferreira, Paula M.T.. Corresponding author: Oliveira, Carlos B.P.. "Synthesis of a new biologically relevant peptide-based hydrogel for biomedical applications". Paper presented in II Symposium on Applied Biochemistry, 2021, 2021.
  6. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Synthesis and biological activity activity of novel CD1d glycolipid antigens". Paper presented in International Carbohydrate Symposium 2014 (Bangalore, India), 2014.
  7. Jervis, Peter; Besra, Gurdyal S.; Cox, Liam R. "Novel glycolipids for activating CD1d-restricted NKT cells". Paper presented in International Symposium on CD1 and NKT cells 2013 (Tours, France), 2013.
  8. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Labeled CD1d glycolipid agonists for studying NKT cells". Paper presented in International Symposium on CD1 and NKT cells 2011 (Chicago, USA), 2011.
  9. Jervis, Peter; Cox, Liam R; Besra, Gurdyal S.. "Synthesis and bioloigical evaluation of 6-N-derivatized alpha-galactosyl ceramides". Paper presented in Eurocarb conference 2011 (Sorrento, Italy), 2011.
Journal article
  1. Ramin Javahershenas; Jianlin Han; Mosstafa Kazemi; Peter J. Jervis. "Recent Advances in the Application of 2-Aminobenzothiazole to the Multicomponent Synthesis of Heterocycles". ChemistryOpen (2024): http://dx.doi.org/10.1002/open.202400185.
    10.1002/open.202400185
  2. Carlos B. P. Oliveira; André Carvalho; Renato B. Pereira; David M. Pereira; Loic Hilliou; Peter J. Jervis; José A. Martins; Paula M. T. Ferreira. "New Supramolecular Hydrogels Based on Diastereomeric Dehydrotripeptide Mixtures for Potential Drug Delivery Applications". Gels (2024): https://doi.org/10.3390/gels10100629.
    10.3390/gels10100629
  3. Ramin Javahershenas; Jianlin Han; Mosstafa Kazemi; Peter J. Jervis. "Recent Advances in the Multicomponent Synthesis of Heterocycles using Thiosemicarbazide". ChemistrySelect (2024): https://doi.org/10.1002/slct.202401496.
    10.1002/slct.202401496
  4. Daniela Correia da Silva; Peter J. Jervis; José A. Martins; Patrícia Valentão; Paula M.T. Ferreira; David M. Pereira. "Fisetin derivatives exhibit enhanced anti-inflammatory activity and modulation of endoplasmic reticulum stress". International Immunopharmacology 119 (2023): 110178-110178. http://dx.doi.org/10.1016/j.intimp.2023.110178.
    10.1016/j.intimp.2023.110178
  5. Suzanne E. Engelen; Francesca A. Ververs; Angela Markovska; Christoffer Lagerholm; Jordan Kraaijenhof; Laura I.E. Yousif; Yasemin-Xiomara Zurke; et al. "Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T-cells". JCI Insight 8 9 (2023): e158089. http://dx.doi.org/10.1172/jci.insight.158089.
    10.1172/jci.insight.158089
  6. Oliveira, Carlos B. P.; Gomes, Valéria; Ferreira, Paula M. T.; Martins, José A.; Jervis, Peter J.. "Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances". Gels 8 11 (2022): 706. https://doi.org/10.3390/gels8110706.
    10.3390/gels8110706
  7. Carlos Oliveira; Renato Pereira; David Pereira; loic hilliou; Tarsila G. Castro; J.A. Martins; Peter J. Jervis; Paula MT Ferreira. Corresponding author: Peter J. Jervis. "Aryl-Capped Lysine-Dehydroamino Acid Dipeptide Supergelators as Potential Drug Release Systems". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/19/11811.
    10.3390/ijms231911811
  8. Peter J. Jervis. Corresponding author: Peter J. Jervis. "Hydrogels in Regenerative Medicine and Other Biomedical Applications". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/6/3270.
    10.3390/ijms23063270
  9. Carlos B.P. Oliveira; Sérgio R.S. Veloso; Castanheira, Elisabete M. S.; Figueira, Pedro; Carvalho, Alexandra; hilliou, loic; Pereira, Renato B.; et al. Corresponding author: Jervis, Peter. "An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration - prepared from a known folate receptor ligand". Soft Matter 18 20 (2022): 3955-3966. http://dx.doi.org/10.1039/d2sm00121g.
    10.1039/d2sm00121g
  10. Amorim C; Veloso SRS; Castanheira EMS; Hilliou L; Pereira RB; Pereira DM; Martins JA; Jervis PJ; Ferreira PMT. Corresponding author: Jervis PJ. "Bolaamphiphilic Bis-Dehydropeptide Hydrogels as Potential Drug Release Systems". Gels (2021): https://www.mdpi.com/2310-2861/7/2/52.
    Open access • 10.3390/gels7020052
  11. Veloso SRS; Jervis PJ; Silva JFG; Hilliou L; Moura C; Pereira DM; Coutinho PJG; et al. "Supramolecular ultra-short carboxybenzyl-protected dehydropeptide-based hydrogels for drug delivery". Materials Science and Engineering: C 122 (2021): 111869. http://dx.doi.org/10.1016/j.msec.2021.111869.
    10.1016/j.msec.2021.111869
  12. Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT. Corresponding author: Jervis PJ. "Dehydropeptide Supramolecular Hydrogels and Nanostructures as Potential Peptidomimetic Biomedical Materials". International Journal of Molecular Science (2021): https://www.mdpi.com/1422-0067/22/5/2528.
    10.3390/ijms22052528
  13. Jervis PJ; Hilliou L; Pereira RB; Pereira DM; Martins JA; Ferreira PMT. Corresponding author: Jervis PJ. "Evaluation of a Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Supramolecular Hydrogel". Nanomaterials (2021): https://www.mdpi.com/2079-4991/11/3/704.
    10.3390/nano11030704
  14. Kharkwal, Shalu Sharma; Johndrow, Christopher T.; Veerapen, Natacha; Kharkwal, Himanshu; Saavedra-Avila, Noemi A.; Carreño, Leandro J.; Rothberg, Samantha; et al. "Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy". Cancer Research 81 7 (2021): 1788-1801. https://doi.org/10.1158/0008-5472.can-20-2219.
    10.1158/0008-5472.can-20-2219
  15. Moreira R; Jervis PJ; Carvalho A; Ferreira, PMT; Martin JA; Valentao P; Andrade PB; Pereira DM. Corresponding author: Jervis PJ. "Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors". Pharmaceutics (2020): http://dx.doi.org/10.3390/pharmaceutics12020122.
    10.3390/pharmaceutics12020122
  16. Velosa SRS; Martins JA; Hilliou L; Amorim CO; Amaral VS; Almeida BG; Jervis PJ; et al. "Dehydropeptide-based plasmonic magnetogels: a supramolecular composite nanosystem for multimodal cancer therapy". Journal of Materials Chemistry B (2020): http://dx.doi.org/10.1039/c9tb01900f.
    10.1039/c9tb01900f
  17. Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT. "Exploring the properties and potential biomedical applications of NSAID-capped peptide hydrogels". Soft Matter 16 44 (2020): 10001-10012. http://dx.doi.org/10.1039/d0sm01198c.
    10.1039/d0sm01198c
  18. Veerapen N; Kharkwal SS; Jervis P; Bhowruth V; Besra AK; North SJ; Haslam SM; et al. "Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.". Bioconjugate chemistry (2018): http://europepmc.org/abstract/med/30085659.
    10.1021/acs.bioconjchem.8b00484
  19. Cox JA; Mugumbate G; Del Peral LV; Jankute M; Abrahams KA; Jervis P; Jackenkroll S; et al. "Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.". Scientific reports (2016): http://europepmc.org/abstract/med/27982051.
    10.1038/srep38986
  20. Saez de Guinoa J; Jimeno R; Farhadi N; Jervis PJ; Cox LR; Besra GS; Barral P. "CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.". EMBO reports (2016): http://europepmc.org/abstract/med/27799287.
    10.15252/embr.201642412
  21. Cox JA; Abrahams KA; Alemparte C; Ghidelli-Disse S; Rullas J; Angulo-Barturen I; Jervis PJ; et al. "THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria.". Nature microbiology (2016): http://europepmc.org/abstract/med/27571973.
    10.1038/nmicrobiol.2015.6
  22. Dossa RG; Alperin DC; Garzon D; Mealey RH; Brown WC; Jervis PJ; Besra GS; Cox LR; Hines SA. "In contrast to other species, a-Galactosylceramide (a-GalCer) is not an immunostimulatory NKT cell agonist in horses.". Developmental and comparative immunology (2014): http://europepmc.org/abstract/med/25445911.
    10.1016/j.dci.2014.11.005
  23. Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Jervis PJ; et al. "Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.". PloS one (2014): http://europepmc.org/abstract/med/25255287.
    10.1371/journal.pone.0108383
  24. Arora P; Baena A; Yu KO; Saini NK; Kharkwal SS; Goldberg MF; Jervis PJ; et al. "A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens.". Immunity (2014): http://europepmc.org/abstract/med/24412610.
    10.1016/j.immuni.2013.12.004
  25. Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR. "Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.". Bioconjugate chemistry (2013): http://europepmc.org/abstract/med/23458425.
    10.1021/bc300556e
  26. Nguyen TK; Koets AP; Vordermeier M; Jervis PJ; Cox LR; Graham SP; Santema WJ; et al. "The bovine CD1D gene has an unusual gene structure and is expressed but cannot present a-galactosylceramide with a C26 fatty acid.". International immunology (2012): http://europepmc.org/abstract/med/22968995.
    10.1093/intimm/dxs092
  27. Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS. "New CD1d agonists: synthesis and biological activity of 6"-triazole-substituted a-galactosyl ceramides.". Bioorganic & medicinal chemistry letters 22 13 (2012): 4348-4352. http://europepmc.org/abstract/med/22652050.
    Open access • Published • 10.1016/j.bmcl.2012.05.009
  28. Salio M; Ghadbane H; Shepherd D; Cypen J; Aichinger M; Jervis PJ; Besra GS; Cresswell P; Cerundolo V. "Combined functional and kinetic measurements to address the role of saposins in loading CD1d molecules with iNKT cell agonists". Molecular Immunology 51 1 (2012): 38-39. http://dx.doi.org/10.1016/j.molimm.2012.02.116.
    10.1016/j.molimm.2012.02.116
  29. Jervis PJ; Moulis M; Jukes JP; Ghadbane H; Cox LR; Cerundolo V; Besra GS. "Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric a-galactosyl ceramide analogues.". Carbohydrate research (2012): http://europepmc.org/abstract/med/22445102.
    10.1016/j.carres.2012.02.034
  30. Jervis PJ; Cox LR; Besra GS. "Synthesis of a versatile building block for the preparation of 6-N-derivatized a-galactosyl ceramides: rapid access to biologically active glycolipids.". The Journal of organic chemistry (2010): http://europepmc.org/abstract/med/21155575.
    10.1021/jo102064p
  31. Jervis PJ; Veerapen N; Bricard G; Cox LR; Porcelli SA; Besra GS. "Synthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramides.". Bioorganic & medicinal chemistry letters (2010): http://europepmc.org/abstract/med/20529677.
    10.1016/j.bmcl.2010.05.010
  32. Audouard C; Bettaney K; Doan CT; Rinaudo G; Jervis PJ; Percy JM. "An appraisal of oxoketene cycloaddition methodology for the synthesis of 2,6-dideoxysugars and fluorinated 2,6-dideoxysugars.". Organic & biomolecular chemistry (2009): http://europepmc.org/abstract/med/19343243.
    10.1039/b817672h
  33. Grainer RS; Jervis PJ. "Synthesis by Extrusion". Science of Synthesis (2009): https://science-of-synthesis.thieme.com/app/text/?id=SD-046-00194.
    DOI: 10.1055/sos-SD-046-00194
  34. Jervis PJ; Cox LR. "Total synthesis and proof of relative stereochemistry of (-)-aureonitol.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18774862.
    10.1021/jo801338t
  35. Beignet J; Jervis PJ; Cox LR. "Temporary silicon connection strategies in intramolecular allylation of aldehydes with allylsilanes.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18557649.
    10.1021/jo800824x
  36. Ramalho R; Jervis PJ; Kariuki BM; Humphries AC; Cox LR. "A Brønsted acid mediated cascade enone synthesis from aldehydes containing a tethered propargylsilane.". The Journal of organic chemistry (2008): http://europepmc.org/abstract/med/18197686.
    10.1021/jo702351s
  37. Jervis PJ; Kariuki BM; Cox LR. "Stereoselective synthesis of 3,4-disubstituted tetrahydrofurans and 2,3,4-trisubstituted tetrahydrofurans using an intramolecular allylation strategy employing allylsilanes". Tetrahedron Letters 49 16 (2008): 2514-2518. https://www.sciencedirect.com/science/article/pii/S004040390800316X?via%3Dihub.
    https://doi.org/10.1016/j.tetlet.2008.02.088
  38. Jervis PJ; Cox LR. "Tether-directed synthesis of highly substituted oxasilacycles via an intramolecular allylation employing allylsilanes.". Beilstein journal of organic chemistry (2007): http://europepmc.org/abstract/med/17288602.
    10.1186/1860-5397-3-6
  39. Jervis PJ; Kariuki BM; Cox LR. "Stereoselective synthesis of 2,4,5-trisubstituted tetrahydropyrans using an intramolecular allylation strategy.". Organic letters (2006): http://europepmc.org/abstract/med/16986972.
    10.1021/ol061957v
Preprint
  1. Carlos Oliveira; Sérgio Veloso; Elisabete Castanheira; Loic Hilliou; Renato Pereira; David Pereira; José Alberto Martins; Paula Ferreira; Peter Jervis. "An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration - prepared from a known folate receptor ligand". 2022. https://doi.org/10.26434/chemrxiv-2022-snfj4.
    10.26434/chemrxiv-2022-snfj4
Thesis / Dissertation
  1. "Stereoselective intramolecular allylation routes to oxygen-containing heterocycles". PhD, University of Birmingham College of Engineering and Physical Sciences, 2008.
  2. "The synthesis of 2,6-dideoxy- and 2,6-dideoxy-6-fluoro-sugars". Master, University of Leicester, 2004.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2021/10/22 An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration - prepared from a known folate receptor ligand ChemBioGels2021 International Symposium
(Braga, Portugal)
2021/05/13 Development of new supramolecular hypergelators based on dehydropeptide derivatives. Dar Asas à Investigação
Universidade do Minho, Braga
2021/04/10 Novel hydrogels for drug delivery applications III Jornadas da Ciência
University of Minho (Braga, Portugal)
2012/07/23 Design, Synthesis, and Functional Activity of Labeled CD1d Glycolipid Agonists International Carbohydrate Symposium 2012 (Madrid, Spain)
Madrid (Madrid, Spain)

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2021/10/21 - 2021/10/22 ChemBioGels2021 Provided a forum for discussion and dissemination of the scientific area of Supramolecular Materials and their applications. Online platform for the presentation and discussion of emerging topics in Supramolecular Materials with biomedical applications such as controlled drug delivery, cell culture media and tissue engineering, functional textiles and theranostic agents. (2021/10/21 - 2021/10/22) (2021/10/21 - 2021/10/22)
Conference (Member of the Organising Committee)

Consulting

Activity description Institution / Organization
2020/04/01 - Current Guest editor for a Special Issue in the International Journal of Molecular Sciences: "Hydrogels in Regenerative Medicine and Other Biomedical Applications" MDPI AG, Switzerland
2017/01/06 - 2017/09/30 STEM ambassador - A STEM Ambassador is a voluntary role undertaken by someone who has a passion and/or professional knowledge of STEM subjects. Our volunteers give their time and enthusiasm to work with young people in schools and in the community, with the shared goal of inspiring the next generation to continue a STEM pathway. This programme is supported by UK Research and Innovation. Concept Life Sciences Chapel-en-le-Frith, United Kingdom

Journal scientific committee

Journal title (ISSN) Publisher
2021/06/03 - Current Gels MDPI
2021/03/03 - Current Molecules MDPI
2020/09/29 - Current Antioxidants MDPI
2020/05/05 - Current Pharmaceutics MDPI
2020/02/14 - Current International Journal of Molecular Sciences (1422-0067) MDPI
Distinctions

Award

2007 Winner best poster at Chemistry Postgraduate Symposium 2007
University of Birmingham College of Engineering and Physical Sciences, United Kingdom